Results 61 to 70 of about 2,698,478 (214)
ABSTRACT Tuberculosis remains a major public health threat globally, with drug‐resistant strains undermining treatment efficacy. We analyzed 126 Mycobacterium tuberculosis (M. tuberculosis) isolates with diverse drug resistance spectra and selected 35 for whole genome sequencing (WGS) using Illumina NextSeq, SMRT PacBio Onso and SMRT PacBio Revio ...
Unarine Matodzi +5 more
wiley +1 more source
Aim. To identify risk factors for adverse drug reactions (ADRs) in patients co-infected with multidrug-resistant tuberculosis (MDR-TB), HIV and viral hepatitis C (HCV). Materials and methods.
Anastasiia V. Kukurika
doaj +1 more source
Objective: To study magnetic microspheres of mesalamine (5-aminosalicylic acid) for colon drug delivery. Methods: Magnetic microspheres were prepared by solvent evaporation technique for use in the application of magnetic carrier technology.
Satinder Kakar +2 more
doaj +1 more source
Abstract figure legend Suboptimal maternal nutrition alters placental and developing blood–brain barrier (BBB) protective function and is associated with increased fetal brain vulnerability. In the placenta, nutritional adversity may reduce the exchange surface area and promote meta‐inflammation, compromising barrier efficiency in a model‐ and context ...
Kristin L. Connor +4 more
wiley +1 more source
The Bromination of p-Aminosalicylic Acid, Sodium p-Aminosalicylate and m-Aminophenol
Summary The bromination of p-aminosalicylic acid, sodium p-aminosalicylate and m-aminophenol has been studied using a variable excess of bromide/bromate solution. p-Aminosalicylic acid, sodium p-aminosalicylate and m-amino phenol brominate
D Simmonite
core +1 more source
Derivatives of 4- or 5-aminosalicylic acid
The present invention provides new derivatives of 4- or 5-aminosalicylic acid, and a pharmaceutical composition containing these derivatives of 4- or 5-aminosalicylic acid as active ingredients, useful for the treatment of intestinal diseases such as ...
A. SPARATORE +5 more
core +1 more source
The culprit of mesalamine intolerance: case series and literature review
Background Mesalamine is a first-line drug in the treatment of inflammatory bowel diseases, while its intolerance occasionally occurs in clinical practice.
Cheng Xie +5 more
doaj +1 more source
Medjool date seeds were dried, milled, and extracted (80°C, 180 min), followed by centrifugation (1000 rpm, 15 min) and BCA analysis to obtain the polysaccharide fraction (MDSP), which was characterized by TEM, FTIR, XPS, NMR, UV‐Vis, and TGA. In Balb/c mice with DSS‐induced colitis (2.25% DSS, Day 1.15), oral administration of MDSP‐H (300 mg/Kg ...
Sadeeq Ullah +10 more
wiley +1 more source
OTE attenuated the dextran sulfate sodium (DSS)–induced colitis by preserving intestinal barrier integrity, reducing oxidative stress and regulating inflammatory cytokines associated with gut microbiota–SCFAs–IL‐22 axis. ABSTRACT This study was conducted to investigate the protective effect of oolong tea extracts (OTEs) on colitis and explore its ...
Wenwen Fang +9 more
wiley +1 more source
Mesalazine- (5-aminosalicylic acid-) containing products are a well-known treatment for inflammatory bowel disease, often as first line. Myocarditis is recognized as a very rare possible side effect of this drug treatment. We present a case of mesalazine-
Michele Sorleto +2 more
doaj +1 more source

